News

News
Partner news

Philogen Announces Options Exercise by Janssen

Read full story
Partner news

RefleXion Raises $100 Million for Cancer Treatment Commercialization

Read full story
Partner news

Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies

Read full story
Partner news

Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Collaboration with National Academy of Medicine to Help People Live Longer, Healthier Lives

Read full story
Partner news

HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing

Read full story
Other news

New Johnson & Johnson Nurses Innovate QuickFire Challenge in Perioperative Care launched at AORN Expo

Read full story
JNJ Press releases

Johnson & Johnson Innovation and Children’s National Health System* to Launch JLABS @ Washington, DC at the new Children’s National Research and Innovation Campus in 2020

Read full story
Partner news

BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-335140

Read full story
Partner news

Joint Purification Systems, Inc. Announces $7.8 Million Series A Financing

Read full story
Partner news

ViaCyte Substantially Expands Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications

Read full story
Partner news

ViaCyte Awarded NIH SBIR Grant to Support In Vitro Development of Stem Cell-Derived Functional Human Pancreatic Beta Cells

Read full story
JNJ Press releases

Janssen Announces Worldwide Development and Commercialization Collaboration with Bristol-Myers Squibb to Advance a Next-Generation Therapy for Cardiovascular Diseases

Read full story
Partner news

RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment

Read full story
In the media

J&J Innovation Talks CNS Partnering And Alzheimer's Challenges

Read full story